Community-acquired multi-drug resistant Escherichia coli in a patient presenting with pyelonephritis

Amreen Dinani; Carl Urban; Rita Colon-Urban; Wehbeh Wehbeh

doi:10.1097/IPC.0b013e3181e928bc

Community-acquired multi-drug resistant Escherichia coli in a patient presenting with pyelonephritis

Amreen Dinani, Carl Urban, Rita Colon-Urban, Wehbeh Wehbeh

Research output: Contribution to journal › Article › peer-review

Abstract

TEM and SHV extended-spectrum β-lactamases (ESBLs) used to be the dominant ESBLs in the 1990s, but more recently, the emergence of CTX-M enzymes have been increasingly recognized worldwide. Gram-negative rods harboring these β-lactamases represent a significant challenge to both clinicians and microbiologists due to the increasing number of reported cases of bacteria-producing ESBLs from the community. We highlight the case of a CTX-M-15-producing Escherichia coli urinary tract isolate causing infection in a patient from the community with no significant risk factors for acquiring E. coli harboring blaCTX-M.

Original language	English
Pages (from-to)	59-60
Number of pages	2
Journal	Infectious Diseases in Clinical Practice
Volume	19
Issue number	1
DOIs	https://doi.org/10.1097/IPC.0b013e3181e928bc
State	Published - Jan 2011
Externally published	Yes

Keywords

ESBl
Escherichia coli
community-acquired infection
multi-drug resistant organisms

Access to Document

10.1097/IPC.0b013e3181e928bc

Cite this

@article{7c9cd4adc2a84953b5469ec901ba2727,

title = "Community-acquired multi-drug resistant Escherichia coli in a patient presenting with pyelonephritis",

abstract = "TEM and SHV extended-spectrum β-lactamases (ESBLs) used to be the dominant ESBLs in the 1990s, but more recently, the emergence of CTX-M enzymes have been increasingly recognized worldwide. Gram-negative rods harboring these β-lactamases represent a significant challenge to both clinicians and microbiologists due to the increasing number of reported cases of bacteria-producing ESBLs from the community. We highlight the case of a CTX-M-15-producing Escherichia coli urinary tract isolate causing infection in a patient from the community with no significant risk factors for acquiring E. coli harboring blaCTX-M.",

keywords = "ESBl, Escherichia coli, community-acquired infection, multi-drug resistant organisms",

author = "Amreen Dinani and Carl Urban and Rita Colon-Urban and Wehbeh Wehbeh",

year = "2011",

month = jan,

doi = "10.1097/IPC.0b013e3181e928bc",

language = "English",

volume = "19",

pages = "59--60",

journal = "Infectious Diseases in Clinical Practice",

issn = "1056-9103",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "1",

}

TY - JOUR

T1 - Community-acquired multi-drug resistant Escherichia coli in a patient presenting with pyelonephritis

AU - Dinani, Amreen

AU - Urban, Carl

AU - Colon-Urban, Rita

AU - Wehbeh, Wehbeh

PY - 2011/1

Y1 - 2011/1

N2 - TEM and SHV extended-spectrum β-lactamases (ESBLs) used to be the dominant ESBLs in the 1990s, but more recently, the emergence of CTX-M enzymes have been increasingly recognized worldwide. Gram-negative rods harboring these β-lactamases represent a significant challenge to both clinicians and microbiologists due to the increasing number of reported cases of bacteria-producing ESBLs from the community. We highlight the case of a CTX-M-15-producing Escherichia coli urinary tract isolate causing infection in a patient from the community with no significant risk factors for acquiring E. coli harboring blaCTX-M.

AB - TEM and SHV extended-spectrum β-lactamases (ESBLs) used to be the dominant ESBLs in the 1990s, but more recently, the emergence of CTX-M enzymes have been increasingly recognized worldwide. Gram-negative rods harboring these β-lactamases represent a significant challenge to both clinicians and microbiologists due to the increasing number of reported cases of bacteria-producing ESBLs from the community. We highlight the case of a CTX-M-15-producing Escherichia coli urinary tract isolate causing infection in a patient from the community with no significant risk factors for acquiring E. coli harboring blaCTX-M.

KW - ESBl

KW - Escherichia coli

KW - community-acquired infection

KW - multi-drug resistant organisms

UR - http://www.scopus.com/inward/record.url?scp=78651430172&partnerID=8YFLogxK

U2 - 10.1097/IPC.0b013e3181e928bc

DO - 10.1097/IPC.0b013e3181e928bc

M3 - Article

AN - SCOPUS:78651430172

SN - 1056-9103

VL - 19

SP - 59

EP - 60

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

IS - 1

ER -

Community-acquired multi-drug resistant Escherichia coli in a patient presenting with pyelonephritis

Abstract

Keywords

Access to Document

Fingerprint

Cite this